Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00230620

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families With Pulmonary Arteriovenous Malformations

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study will examine genes involved in the vascular dysplasia Hereditary haemorrhagic telangiectasia i(HHT)

Detailed description

Hereditary haemorrhagic telangiectasia (HHT) is a condition inherited as an autosomal dominant trait. Sequencing DNA from affected and unaffected family members allows us to identify disease-causal genes. Sequencing these genes allows us to identify what the precise DNA variants are which are causing disease, particularly if linked to functional assays in separate studies.

Conditions

Timeline

Start date
1998-12-01
Primary completion
2030-04-01
Completion
2030-04-01
First posted
2005-10-03
Last updated
2023-09-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00230620. Inclusion in this directory is not an endorsement.